Logo image of MB.MI

MEDIOBANCA SPA (MB.MI) Stock Fundamental Analysis

BIT:MB - IT0000062957 - Common Stock

21.4 EUR
+0.42 (+2%)
Last: 8/22/2025, 11:16:01 AM
Fundamental Rating

3

Overall MB gets a fundamental rating of 3 out of 10. We evaluated MB against 96 industry peers in the Banks industry. While MB is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, MB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MB was profitable.
MB had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MB reported negative operating cash flow in multiple years.
MB.MI Yearly Net Income VS EBIT VS OCF VS FCFMB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

1.2 Ratios

The Return On Assets of MB (1.92%) is better than 95.83% of its industry peers.
MB has a better Return On Equity (17.82%) than 91.67% of its industry peers.
Industry RankSector Rank
ROA 1.92%
ROE 17.82%
ROIC N/A
ROA(3y)1.23%
ROA(5y)1.13%
ROE(3y)10.79%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
MB.MI Yearly ROA, ROE, ROICMB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

The Profit Margin of MB (34.96%) is better than 85.42% of its industry peers.
In the last couple of years the Profit Margin of MB has grown nicely.
MB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 34.96%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.97%
PM growth 5Y9.17%
GM growth 3YN/A
GM growth 5YN/A
MB.MI Yearly Profit, Operating, Gross MarginsMB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1

2. Health

2.1 Basic Checks

MB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MB has been reduced compared to 1 year ago.
The number of shares outstanding for MB has been reduced compared to 5 years ago.
The debt/assets ratio for MB has been reduced compared to a year ago.
MB.MI Yearly Shares OutstandingMB.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
MB.MI Yearly Total Debt VS Total AssetsMB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

A Debt/Equity ratio of 2.82 is on the high side and indicates that MB has dependencies on debt financing.
MB's Debt to Equity ratio of 2.82 is on the low side compared to the rest of the industry. MB is outperformed by 64.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.82
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.22%
MB.MI Yearly LT Debt VS Equity VS FCFMB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MB.MI Yearly Current Assets VS Current LiabilitesMB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.38% over the past year.
Measured over the past 5 years, MB shows a small growth in Earnings Per Share. The EPS has been growing by 4.34% on average per year.
Looking at the last year, MB shows a small growth in Revenue. The Revenue has grown by 2.05% in the last year.
MB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.61% yearly.
EPS 1Y (TTM)15.38%
EPS 3Y4.6%
EPS 5Y4.34%
EPS Q2Q%5.96%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y4.97%
Revenue growth 5Y4.61%
Sales Q2Q%-2.87%

3.2 Future

Based on estimates for the next years, MB will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.91% on average per year.
MB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.17% yearly.
EPS Next Y19.1%
EPS Next 2Y21.37%
EPS Next 3Y16.43%
EPS Next 5Y11.91%
Revenue Next Year15.58%
Revenue Next 2Y13.49%
Revenue Next 3Y10.4%
Revenue Next 5Y8.17%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MB.MI Yearly Revenue VS EstimatesMB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
MB.MI Yearly EPS VS EstimatesMB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.38, which indicates a rather expensive current valuation of MB.
MB's Price/Earnings ratio is rather expensive when compared to the industry. MB is more expensive than 88.54% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.76, MB is valued a bit cheaper.
MB is valuated correctly with a Price/Forward Earnings ratio of 13.84.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MB indicates a slightly more expensive valuation: MB is more expensive than 76.04% of the companies listed in the same industry.
MB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.91.
Industry RankSector Rank
PE 20.38
Fwd PE 13.84
MB.MI Price Earnings VS Forward Price EarningsMB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MB.MI Per share dataMB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

MB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
MB's earnings are expected to grow with 16.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.07
PEG (5Y)4.7
EPS Next 2Y21.37%
EPS Next 3Y16.43%

6

5. Dividend

5.1 Amount

MB has a Yearly Dividend Yield of 5.27%, which is a nice return.
Compared to an average industry Dividend Yield of 4.86, MB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, MB pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.27%

5.2 History

On average, the dividend of MB grows each year by 24.10%, which is quite nice.
Dividend Growth(5Y)24.1%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MB's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP0%
EPS Next 2Y21.37%
EPS Next 3Y16.43%
MB.MI Yearly Income VS Free CF VS DividendMB.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

MEDIOBANCA SPA

BIT:MB (8/22/2025, 11:16:01 AM)

21.4

+0.42 (+2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-09 2025-11-09
Inst Owners21.09%
Inst Owner ChangeN/A
Ins Owners7.66%
Ins Owner ChangeN/A
Market Cap17.83B
Analysts72.73
Price Target19.82 (-7.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.27%
Yearly Dividend1.38
Dividend Growth(5Y)24.1%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.92%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)-0.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.37%
Min Revenue beat(4)-3.66%
Max Revenue beat(4)6.01%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.86%
PT rev (3m)11.8%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.24%
Revenue NY rev (3m)1.24%
Valuation
Industry RankSector Rank
PE 20.38
Fwd PE 13.84
P/S 3.13
P/FCF N/A
P/OCF N/A
P/B 1.59
P/tB 1.59
EV/EBITDA N/A
EPS(TTM)1.05
EY4.91%
EPS(NY)1.55
Fwd EY7.23%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.84
BVpS13.42
TBVpS13.42
PEG (NY)1.07
PEG (5Y)4.7
Profitability
Industry RankSector Rank
ROA 1.92%
ROE 17.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 34.96%
GM N/A
FCFM N/A
ROA(3y)1.23%
ROA(5y)1.13%
ROE(3y)10.79%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.97%
PM growth 5Y9.17%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 2.82
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC5.22%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3Y4.6%
EPS 5Y4.34%
EPS Q2Q%5.96%
EPS Next Y19.1%
EPS Next 2Y21.37%
EPS Next 3Y16.43%
EPS Next 5Y11.91%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y4.97%
Revenue growth 5Y4.61%
Sales Q2Q%-2.87%
Revenue Next Year15.58%
Revenue Next 2Y13.49%
Revenue Next 3Y10.4%
Revenue Next 5Y8.17%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A